top of page

PNEUMONIX ATTENDS ASPIRE INVESTOR READINESS PROGRAM THROUGH VENTUREWELL

PneumoNIX was selected as 1 of 15 MedTech start-ups to attend VentureWell’s investor readiness program. The program ensures the companies have a solidified go-to-market plan with planned milestones and a comprehensive due diligence deal room package. Furthermore, PneumoNIX secured partnerships to help with product launch and market adoption.


1 view0 comments

Recent Posts

See All

PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE I GRANT

PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced that it received Phase I SBIR grants from the NSF. The awards w

bottom of page